Takayuki Ueno

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Takayuki Ueno, Masakazu Toi, Hisashi Saji et al. · PubMed · 2000 · 711 citations

Breast Oncology, Immunology, Pathology +17

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

Maria Hägg Olofsson, Takayuki Ueno, Yang Pan et al. · Clinical Cancer Research · 2007 · 147 citations · Full text

Processing of Pulmonary Surfactant Protein B by Napsin and Cathepsin H

Takayuki Ueno, Stig Linder, Cheng-Lun Na et al. · Journal of Biological Chemistry · 2004 · 138 citations · Full text